Cinobufotalin
Malignant Tumor of Small Intestine Metastatic to Liver
Shanghai University of Traditional Chinese MedicinePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
21 Active assets in the Malignant Tumor of Small Intestine Metastatic to Liver cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide National Cancer Institute (NCI) | Phase 2 | BB |
ETOPOSIDE Cancer Research UK | Phase 2 | BB |
VINCRISTINE SULFATE Cancer Research UK | Phase 2 | BB |
FILGRASTIM Cancer Research UK | Phase 2 | BB |
Inno-206 Cancer Research UK | Phase 2 | B |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →